In April 1984, Dr. Robert Gallo filed a United States patent application for his invention, the HIV/AIDS Virus. Normally, when a patent is filed and approved, as Dr. Gallo’s was, anyone who uses the product or invention owes a royalty payment to the inventor. Thus, holding the intellectual property laws to their fullest interpretations, one must only wonder why Dr. Gallo has yet to file a lawsuit seeking to recover damages from the usage of his invention? As odd as this scenario may sound, it bears need for additional scrutiny.
The scientific evidence is complete and compelling, the AIDS Virus is a designer bi-product of the U.S. Special Virus program. The Special Virus program was a federal virus development program that persisted in the United States from 1962 until 1978. The U.S. Special Virus was then added as ‘compliment’ to vaccine inoculations in Africa and Manhattan. Shortly thereafter the world was overwhelmed with mass infections of a human retrovirus that differed from any known human disease, it was highly contagious and more importantly, it could kill.